Ads
related to: What is the Cancer Research Institute?We're Celebrating 110 Years of Making Life Better For Cancer Patients And Their Families. All People Deserve a Fair & Just Opportunity to Prevent, Detect, Treat, & Survive Cancer.
- You Can Help Save Lives
Donate Today To Help Fund
Groundbreaking Research For A Cure.
- Donate A Vehicle
Arrange A Free Pick-Up Time.
Your Vehicle Will Help Save Lives.
- Programs & Services
Helping Patients Get The Support
They So Desperately Deserve & Need.
- More Ways To Give
Other Ways You Can Contribute to
Finding Cures and Fighting Cancer.
- Gifts Of Securities
Quickly And Securely Donate Stock.
Submit Your Gift Electronically.
- Become a Monthly Donor
Be Part Of The Next Breakthrough.
Your Recurring Gift Saves Lives.
- You Can Help Save Lives
Discover a world immune to cancer with CRI-70 years of groundbreaking research! Be a part of history-70 years of transforming cancer treatment with immunotherapy!
Join Molecular Oncology - an open access journal for new discoveries in cancer research. Increase your reach - open access papers usually receive 3x more downloads
Search results
People also ask
What is the Cancer Research Institute?
Is the Cancer Research Institute a nonprofit organization?
Who founded the Cancer Research Institute?
Who is the founder of the National Cancer Institute?
Bring to Life More Cures, Together. Become part of CRI’s mission to create a world immune to cancer. Donate Now. The Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to advancing immunotherapy to treat, control, and cure all cancers.
- Our Impact
The Cancer Research Institute is a top-rated nonprofit...
- CRI Network
The William B. Coley Award for Distinguished Research in...
- CRI Discovery
The Cancer Research Institute Technology Impact Award...
- Scientific Advisory Council
Scientific Advisory Council. Composed of leaders in...
- Associate Board
The Cancer Research Institute Associate Board is a group of...
- Our Team
Jill O’Donnell-Tormey, PhD, is the chief executive officer...
- Our Impact
- Bacterial Toxins and Treatments
- The “Father of Cancer Immunotherapy”
- Expansion and Education
- Recruiting and Training Scientific Talent
- Fostering Global Collaboration
- Increased Efficiency Through Consolidation
- Innovation and Transition
- Reaching Patients and Caregivers
- People X Biology X Data
- The Path Forward
Helen Coley Nauts learned that, in the early 1890s, her father, Dr. William B. Coley, had observed that some cancer patients experienced spontaneous remission of their tumors in a considerable number of cases where they contracted acute bacterial infections. Convinced that the disappearance of the tumors was somehow connected with the infections, D...
Although the first half of the twentieth century brought great advances in the medical application of the biological sciences, the field of immunology remained a neglected and sparsely populated landscape during these early years. Mrs. Nauts’ groundbreaking work rekindled the medical community’s interest in exploring the link between cancer and the...
Over its 70 years, CRI has undergone several important programmatic evolutions in response to (and often in anticipation of) developments in the field of cancer immunology. The first of these began in 1971, when CRI appointed Lloyd J. Old, MD, a prominent cancer immunologist, to be its medical director. Old set out at once to expand CRI’s programma...
In 1971, CRI established its Postdoctoral Fellowship Program to attract outstanding young scientists to immunology and train them in the best labs under the tutelage of skilled mentors. This investment in the field grew an increasing population of cancer immunologists needing funding at more advanced stages of their careers. To meet this need, the ...
It became apparent that many research centers were working toward common goals, but the lack of communication and teamwork among them was proving a hindrance to the advancement of the field. Research often consists of stand-alone projects that follow their own guidelines. Results are hard to compare and learn from, and proprietary interests often g...
In late 2007, the Irvington Institute for Immunological Research merged with the Cancer Research Institute, combining its postdoctoral fellowship program with CRI’s. During the more than 90 years of its existence, the Irvington Institute established itself as a leading source of postdoctoral fellowship funding for research on immunology and disease...
In 2010, CRI took an important strategic step forward in realizing its mission to conquer cancer through immunotherapy with the launch of the Cancer Vaccine Acceleration Fund. The Fund was an innovative model for philanthropic investment in early-stage clinical development of promising cancer immunotherapies that had been prioritized by our scienti...
As cancer immunotherapy becomes increasingly available as a treatment option for patients, the need grows to provide trusted, easy-to-understand information to patients and caregivers who are trying to make sense of this new approach to cancer treatment. In 2014, the Cancer Research Institute launched a new website devoted to patients and caregiver...
As technology advances, so too does the pace of discovery. Harnessing the vast stores of data being generated by today’s sophisticated laboratory and clinical studies is a critical step toward cancer cures. In 2022, CRI announced new initiatives including a postdoctoral fellowship and intensives designed to train the next generation of tumor immuno...
Today, virtually every major research institution in the world working in immunology and immunotherapy has scientists on staff who have been or are currently being funded by CRI, with fresh talent on the way. The journey begun by Dr. Coley isn’t over. CRI will continue to be a pioneer and leader in bringing immunotherapies to more cancer patients b...
Cancer immunotherapy, also known as immuno-oncology, is a form of cancer treatment that uses the power of the body’s own immune system to prevent, control, and eliminate cancer. Cancer immunotherapy comes in a variety of forms, including targeted antibodies, cancer vaccines, adoptive cell transfer, tumor-infecting viruses, checkpoint ...
News about Rutgers Cancer Institute, Providence Therapeutic Holdings, RWJBarnabas Health
News about HPV, cancer, vaccine
News about breast cancer, Dana-Farber Cancer Institute, pregnancy
Also in the news
The Cancer Research Institute (CRI) is a nonprofit organization dedicated exclusively to advancing immunotherapy to treat, control, and cure all cancers. Our Mission: Save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer.
Our Approach | Cancer Research Institute. Immunotherapy is already saving lives and giving patients hope for a cure. The Path Forward. Ushering in the next wave. Our unique approach is ushering in the next wave of curative immunotherapies.
The Cancer Research Institute (CRI) is a US non-profit organization funding cancer research and based in New York City. They were founded in 1953 to develop immunologically-based treatments for cancer, and despite their name are a funding body for research rather than a research institute themselves, working with other institutes and organizations.
The Cancer Research Institute was founded on January 27, 1953 by Helen Coley Nauts and Oliver R. Grace Sr., two visionary individuals who believed that, together, they could end the devastation of cancer.
Ads
related to: What is the Cancer Research Institute?We're Celebrating 110 Years of Making Life Better For Cancer Patients And Their Families. All People Deserve a Fair & Just Opportunity to Prevent, Detect, Treat, & Survive Cancer.
Discover a world immune to cancer with CRI-70 years of groundbreaking research! Be a part of history-70 years of transforming cancer treatment with immunotherapy!
Join Molecular Oncology - an open access journal for new discoveries in cancer research. Increase your reach - open access papers usually receive 3x more downloads
